The Biology Behind Nucleotide Excision Repair, Oxidative Damage, DNA Sequence Polymorphisms, and Cancer Treatment
نویسندگان
چکیده
INTRODUCTION Can a single polymorphic site help tailor a cancer patient’s chemotherapy regimen? The study by Zhao et al. (1) presented in this issue of Clinical Cancer Research suggests that in fact polymorphic sites in noncoding gene regions may determine how a patient will react to a given chemotherapy and the likelihood of cancer recurrence after treatment. The group focused their investigation on a common polymorphism termed xeroderma pigmentosum group A ( 4) [XPA ( 4)], whereby the fourth nucleotide before the ATG start codon is A in about half the population and G in about the other half (2, 3). The polymorphism is in the Kozak sequence and thus the A form of the allele may affect the translation efficiency of XPA resulting in reduced XPA level and reduced excision repair capacity. Indeed, this group previously reported that the A allele (XPA Avariant in the authors’ terminology) is associated with reduced excision repair capacity (4). In the current study, the authors report that the XPA G variant in which both alleles contain G at the fourth position before the initiation codon is associated with a higher rate of recurrence of superficial bladder cancer after Bacillus Calmette-Guerin (BCG) treatment. The authors report that during the follow-up period of 27.6 months from diagnosis, tumor recurred in 44% of patients with the AA genotype, 62% in those with the AG genotype, and 74% in those with the GG genotype. To explain these findings, the authors suggest that the XPA G variant exhibits increased DNA repair capacity by nucleotide excision repair. This allows cancer cells to bypass the apoptotic response induced by BCG treatment. Nucleotide excision repair is the only human system that protects against the carcinogenic effects of sunlight by removing UV light-induced DNA adducts such as (6–4) photoproducts and cyclobutane thymine dimers (5–8). Along with lightinduced lesions, the excision nuclease recognizes and excises a broad spectrum of bulky lesions such as benzo(a)pyrene, acetylaminofluorene, cisplatin, and psoralen DNA adducts (5). The mechanism of excision repair is highly conserved from E. coli to man and involves a damage recognition step, dual incisions bracketing the lesion, removal of the damage in the form of a 12to 13-nucleotide-long oligomer in E. coli and a 24to 32nucleotide-long oligomer in humans, repair synthesis to fill the resulting gap, and finally ligation of the repair patch. Human nucleotide excision repair has been recently characterized at the biochemical level in considerable detail. Six repair factors, XPA, RPA, XPC, TFIIH, XPG, and XPFERCC1, are necessary and sufficient to remove damage from DNA. A current model for human nucleotide excision repair is as follows: XPA, RPA, and XPC locate the damage site and recruit the TFIIH transcription/repair factor, which contains six polypeptides including helicases XPB and XPD that unwind the DNA around the damage site; the XPG and XPF-ERCC1 subunits are responsible for the 3V and 5V dual incisions, respectively. Repair synthesis proteins replication factor C, proliferating cell nuclear antigen, and DNA polymerases y and q fill the gap, and in the final step, the repair patch is sealed by DNA ligase I (refs. 9, 10; Fig. 1). Mutations in any of the XP A-to-G coding sequences result in XP, a disease characterized by extreme light sensitivity and high incidence of skin cancer. Currently, all known XP cases contain mutations in the coding regions of one of the XP genes. It is conceivable that mutations in the noncoding or nontranscribed regions of the XP genes may cause slight alteration in gene expression so as not to give rise to an overt XP phenotype, but of significant magnitude that subtle repair defects may manifest. Even though nucleotide excision repair is generally thought of as a repair system for bulky adducts, it has been shown that it works with moderate efficiency on nonbulky DNA lesions, such as DNA bases altered by oxidative damage that are usually processed by base excision repair (11, 12). Because of this property, the nucleotide excision repair system plays a backup role for the base excision repair pathway in the removal of such DNA adducts. Reactive oxygen species are by-products of oxidative metabolism and are also produced in great quantities during inflammatory reactions. They induce numerous DNA lesions including thymine glycols, 8-oxoguanine, and cyclodeoxyadenosine. Nucleotide excision repair is capable of removing all of these DNA lesions induced by reactive oxygen species (13, 14). In the study by Zhao et al. (1), the authors propose a mechanism that involves the nucleotide excision repair pathway and its response to oxidative damage, to explain why the XPA G variant is less responsive to BCG treatment. The suggestion is that BCG therapy provokes an inflammatory cellular response, which subsequently results in the production of oxygen radicals and extensive oxidative damage to DNA followed by apoptosis. The XPA G variant was reported to have increased DNA repair capacity (4). This increase in DNA repair capacity may be responsible for removing a greater percentage of oxidative damage from DNA, preventing the apoptotic pathway, and permitting tumor cell survival, rendering BCG ineffective for patients homozygous for the XPA G variant. Received 1/6/05; accepted 1/13/05. Requests for reprints: Aziz Sancar, Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Mary Ellen Jones Building, Campus Box #7260, Chapel Hill, NC 27599-7260. Phone: 919-962-0115; Fax: 919-966-2852; E-mail: [email protected]. D2005 American Association for Cancer Research. Vol. 11, 1355–1357, February 15, 2005 Clinical Cancer Research 1355
منابع مشابه
DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment
Many components of the cell, including lipids, proteins and both nuclear and mitochondrial DNA, are vulnerable to deleterious modifications caused by reactive oxygen species. If not repaired, oxidative DNA damage can lead to disease-causing mutations, such as in cancer. Base excision repair and nucleotide excision repair are the two DNA repair pathways believed to orchestrate the removal of oxi...
متن کاملOGG1 DNA Repair Gene Polymorphism As a Biomarker of Oxidative and Genotoxic DNA Damage
Background: Single nucleotide polymorphisms in 8-oxoguanine DNA glycosylase-1 (OGG1) gene modulates DNA repair capacity and functions as one of the first lines of protective mechanisms against 8-hydroxy-2’-deoxyguanosine (8-OHdG) mutagenicity. OGG1-Cys326 gene polymorphism may decrease DNA repair function, causing oxidative stress due to higher oxidative DNA damage. The main purpose of this stu...
متن کاملNucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment.
INTRODUCTION Can a single polymorphic site help tailor a cancer patient’s chemotherapy regimen? The study by Zhao et al. (1) presented in this issue of Clinical Cancer Research suggests that in fact polymorphic sites in noncoding gene regions may determine how a patient will react to a given chemotherapy and the likelihood of cancer recurrence after treatment. The group focused their investigat...
متن کاملAssociation of -77T>C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population
Objective(s): Coronary artery disease (CAD) is the leading cause of death in both male and female worldwide. The main cause of CAD is the atherosclerosis of coronary arteries, which is, mostly caused by genetic alteration. 50% of such cases occur in mitotic cells where single-strand breaks occur spontaneously or due to ionizing radiation. X-ray repair cross-complementing protein 1 (XRCC1) as a ...
متن کاملThe Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer
Genome instability and impaired DNA repair are hallmarks of carcinogenesis. The study was aimed at evaluating the DNA damage response in H2O2-treated lymphocytes using the alkaline comet assay in bladder cancer (BC) patients as compared to clinically healthy controls, elderly persons, and individuals with chronic inflammations. Polymorphism in DNA repair genes involved in nucleotide excision re...
متن کامل